These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 16265613)
1. Investigating neurocognitive features of hepatitis C virus infection in drug users: potential challenges and lessons learned from the HIV literature. Gonzalez R; Jacobus J; Martin EM Clin Infect Dis; 2005 Jul; 41 Suppl 1():S45-9. PubMed ID: 16265613 [TBL] [Abstract][Full Text] [Related]
3. Drug abuse and hepatitis C infection as comorbid features of HIV associated neurocognitive disorder: neurocognitive and neuroimaging features. Martin-Thormeyer EM; Paul RH Neuropsychol Rev; 2009 Jun; 19(2):215-31. PubMed ID: 19468837 [TBL] [Abstract][Full Text] [Related]
4. The effect of hepatitis C treatment and human immunodeficiency virus (HIV) co-infection on the disease burden of hepatitis C among injecting drug users in Amsterdam. Matser A; Urbanus A; Geskus R; Kretzschmar M; Xiridou M; Buster M; Coutinho R; Prins M Addiction; 2012 Mar; 107(3):614-23. PubMed ID: 21919987 [TBL] [Abstract][Full Text] [Related]
5. Psychiatric barriers to readiness for treatment for hepatitis C Virus (HCV) infection among injection drug users: clinical experience of an addiction psychiatrist in the HIV-HCV coinfection clinic of a public health hospital. Scheft H; Fontenette DC Clin Infect Dis; 2005 Apr; 40 Suppl 5():S292-6. PubMed ID: 15768337 [TBL] [Abstract][Full Text] [Related]
6. Integrating care for hepatitis C virus (HCV) and primary care for HIV for injection drug users coinfected with HIV and HCV. Kresina TF; Bruce RD; Cargill VA; Cheever LW Clin Infect Dis; 2005 Jul; 41 Suppl 1():S83-8. PubMed ID: 16265621 [TBL] [Abstract][Full Text] [Related]
7. Neuropsychological aspects of coinfection with HIV and hepatitis C virus. Hilsabeck RC; Castellon SA; Hinkin CH Clin Infect Dis; 2005 Jul; 41 Suppl 1(Suppl 1):S38-44. PubMed ID: 16265612 [TBL] [Abstract][Full Text] [Related]
8. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users. Devi KhS; Brajachand N; Singh HL; Singh YM J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404 [TBL] [Abstract][Full Text] [Related]
9. Medical management of HIV-hepatitis C virus coinfection in injection drug users. Khalsa JH; Kresina T; Sherman K; Vocci F Clin Infect Dis; 2005 Jul; 41 Suppl 1():S1-6. PubMed ID: 16265605 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China. Chen X; He JM; Ding LS; Zhang GQ; Zou XB; Zheng J Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454 [TBL] [Abstract][Full Text] [Related]
11. Increased hepatitis C virus load among injection drug users infected with human immunodeficiency virus and human T lymphotropic virus type II. Hisada M; Chatterjee N; Zhang M; Battjes RJ; Goedert JJ J Infect Dis; 2003 Sep; 188(6):891-7. PubMed ID: 12964121 [TBL] [Abstract][Full Text] [Related]
12. Claudin-1 gene variants and susceptibility to hepatitis C infection in HIV-1 infected intravenous drug users (an ANRS case-control study). Ghosn J; Fouquet B; Quertainmont Y; Salmon D; Sahali S; Rioux C; Duvivier C; Mole M; Delfraissy JF; Misrahi M J Med Virol; 2015 Apr; 87(4):619-24. PubMed ID: 25611191 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis C infection among drug users in northern Thailand. Jittiwutikarn J; Thongsawat S; Suriyanon V; Maneekarn N; Celentano D; Razak MH; Srirak N; Vongchak T; Kawichai S; Thomas D; Sripaipan T; Netski D; Ananthakrishnan A; Nelson KE Am J Trop Med Hyg; 2006 Jun; 74(6):1111-6. PubMed ID: 16760529 [TBL] [Abstract][Full Text] [Related]
14. Coinfection by human immunodeficiency virus, hepatitis B virus and hepatitis C virus in injecting drug users. Devi KhS; Singh NB; Singh HL; Singh YM J Indian Med Assoc; 2009 Mar; 107(3):144, 146-7. PubMed ID: 19810379 [TBL] [Abstract][Full Text] [Related]
15. The investigation of HIV and HCV infection and risk factors among opiate drug users in Beijing, China. Bao YP; Du C; Lu HY; Lian Z; Qiu Y; Mu Y; Yan SY; Liu ZM Am J Drug Alcohol Abuse; 2012 Mar; 38(2):140-5. PubMed ID: 22175771 [TBL] [Abstract][Full Text] [Related]
16. The neuropsychological and neurological impact of hepatitis C virus co-infection in HIV-infected subjects. Clifford DB; Evans SR; Yang Y; Gulick RM AIDS; 2005 Oct; 19 Suppl 3():S64-71. PubMed ID: 16251830 [TBL] [Abstract][Full Text] [Related]
17. Emotional stress, psychosocial variables and coping associated with hepatitis C virus and human immunodeficiency virus infections in intravenous drug users. Grassi L; Satriano J; Serra A; Biancosino B; Zotos S; Sighinolfi L; Ghinelli F Psychother Psychosom; 2002; 71(6):342-9. PubMed ID: 12411769 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of HCV & HBV infection amongst HIV seropositive intravenous drug users & their non-injecting wives in Manipur, India. Saha MK; Chakrabarti S; Panda S; Naik TN; Manna B; Chatterjee A; Detels R; Bhattacharya SK Indian J Med Res; 2000 Feb; 111():37-9. PubMed ID: 10824464 [TBL] [Abstract][Full Text] [Related]
19. [A study on the prevalence rates of human immunodeficiency virus, hepatitis B virus and hepatitis C virus infections in intravenous drug users]. Wang YC; Xu SH; Li XH; Song AJ; Jia XR; Zhuang H Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Sep; 27(9):777-9. PubMed ID: 17299963 [TBL] [Abstract][Full Text] [Related]
20. Neuropsychiatric aspects of coinfection with HIV and hepatitis C virus. Douaihy A; Hilsabeck RC; Azzam P; Jain A; Daley DC AIDS Read; 2008 Aug; 18(8):425-32, 438-9. PubMed ID: 18770900 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]